BTL Group Logo
BTL Group, a prominent player in the medical solutions sector, has filed a patent infringement lawsuit against Lexter Microelectronic Engineering Systems S.L., the manufacturer of the WonderFace device. This legal action, initiated on October 8, 2025, at the Unified Patent Court in Prague, centers around BTL’s patented technologies associated with its groundbreaking EMFACE® system.
EMFACE® has transformed facial lifting procedures by integrating selective muscle stimulation with radiofrequency heating. This innovative technology has established a new category in aesthetic treatments, utilizing hands-free applicators that enhance the effectiveness of facial procedures.
In a statement addressing the lawsuit, Tomas Schwarz, CEO of the BTL Enterprise Group, emphasized the company’s commitment to safeguarding its intellectual property. “We will vigorously defend our intellectual property to protect the investments of our clients. This lawsuit marks the beginning of our broader effort to take legal action against any third party that we believe infringes upon our innovations,” he stated.
The lawsuit aims to halt the distribution of the WonderFace systems across various countries. A decision in this case will have implications in 18 jurisdictions, showcasing the extensive scope of BTL’s enforcement efforts.
Founded in 1993, BTL Group has positioned itself as a leader in the medical device industry, offering innovative solutions across multiple fields including dermatology, plastic surgery, and rehabilitation. The company boasts over 200 patents and employs more than 600 in-house engineers to drive advancements in medical technology. Its diverse product range includes notable offerings such as EMFACE®, EXION®, EMSCULPT NEO®, and EMSELLA®.
For further details about BTL’s EMFACE technology, interested parties can visit the official website at www.emface.com.
This legal action underscores the competitive nature of the medical technology industry, where innovation is rapidly evolving, and companies seek to protect their advancements vigorously. As BTL moves forward with this lawsuit, the outcome could shape the landscape of facial aesthetic procedures and the technologies that drive them.
